The company’s earnings missed expectations, the latest sign of how medical expenses are squeezing insurers’ government businesses.
Related Posts
Roche’s Parkinson’s Drug Candidate Misses Key Goal in Mid-Stage Study
An experimental Parkinson’s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments […]
Boeing Machinist Strike Adds Cash Crunch to New CEO’s Rescue Mission
Ratings firms are warning that a prolonged work stoppage could sink the jet maker’s debt into junk status.
Rheinmetall Targets $21.2 Billion in Sales by 2027 as Western Defense Budgets Rise
The arms maker forecasts $21.2 billion in sales over the next three years amid higher defense spending in western markets.